Axiom Announces AI-Enabled Contracting Solution, Proven to Improve Efficiency of Contract-Related Legal Tasks by up to 60%
Field tested by Axiom lawyers in actual client engagements, Axiom pairs top-rated legal talent with DraftPilot AI to speed contract reviews, analysis, and redlining, and enhance contract review quality NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Today...
China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results
SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery...
Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25, 2025 GUANGZHOU, China, Feb. 25, 2025 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its...
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)
SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from the ongoing...
Ericsson announces changes to the Executive Team and to the Market Area structure
Per Narvinger, currently Head of Business Area Cloud Software and Services, is appointed Executive Vice President and new Head of Business Area Networks as of March 15, 2025 Jenny Lindqvist, currently Head of Market Area Europe & Latin America,...
BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)
SHANGHAI, Feb. 23, 2025 /PRNewswire/ -- BioCity Biopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist, SC0062, met the 12-week primary endpoint of a reduction in proteinuria in the diabetic kidney disease (DKD)...
Consensus concludes sold-out debut event in Hong Kong and announces return to Asia in 2026
The Hong Kong Convention and Exhibition Centre reached maximum capacity, with nearly 10,000 in-person attendees from over 100 countries, solidifying the conference's position as a marquee event of the region. The conference, and its 350+ side events...
CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA
Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugemalimab in combination with chemotherapy as a new...
Pentera Announces Top Performing Channel Partner Awards
BOSTON, Feb. 25, 2025 /PRNewswire/ -- Pentera, the leader in Automated Security Validation, proudly announced the winners of its 2024 Pentera Partner Awards. The awards recognize business achievements by Pentera's global partner network in driving...
FOUR COUNTRIES SHORTLISTED TO HOST THE GAMES OF THE FUTURE 2027
Brazil, Serbia, South Africa, and Uzbekistan in the race to host the global phygital sports event DUBAI, UAE, Feb. 25, 2025 /PRNewswire/ -- Phygital International (PI), the exclusive rights holders and custodians of The Games of the Future (GOTF),...